Compare ConocoPhillips (COP) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs Sana Biotechnology Inc — how do they compare? ConocoPhillips trades at $125.33 (market cap $151.27B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: ConocoPhillips is far larger — about 133.9× Sana Biotechnology Inc's market cap, and ConocoPhillips pays a 2.67% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| COP | SANA | |
|---|---|---|
Market Cap | $151.27B | $1.13B |
Sector | Energy | Health |
52-Week High | $133.80 | $5.92 |
52-Week Low | $85.66 | $2.68 |
Enterprise Value | $166.87B | $1.05B |
Dividend Yield | 2.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
